1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Baseline characteristics of the fifty patients
VariablesCharacteristics
Age*66 ± 8.3
Male-to-female ratio45:5
Presence of symptoms45 (90%)
    (Stroke:TIA)(20:25)
    (Stable:unstable)(38:7)
Hypertension37 (74%)
DM17 (34%)
Hyperlipidemia9 (18%)
History of previous stroke20 (40%)
Coronary arterial disease15 (30%)
Chronic renal failure2 (4%)
C-reactive protein*1.0 ± 1.8
Homocysteine (umol/L)*16.5 ± 9.2
  • Note:—TIA indicates transient ischemic attack; DM, diabetes mellitus.
  • * Mean ± SD.